Your browser doesn't support javascript.
loading
CCL299, a Benzimidazole Derivative Induces G1 Phase Arrest and Apoptosis in Cancer Cells.
Ohno, Yoshifumi; Yi, Ruirong; Suganami, Akiko; Tamura, Yutaka; Matsumoto, Akio; Matsumoto, Shoji; Saito, Kengo; Shirasawa, Hiroshi.
Afiliação
  • Ohno Y; Department of Molecular Virology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Yi R; Department of Molecular Virology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Suganami A; Department of Bioinformatics, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Tamura Y; Molecular Chirality Research Center, Chiba University, Chiba, Japan.
  • Matsumoto A; Department of Bioinformatics, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Matsumoto S; Molecular Chirality Research Center, Chiba University, Chiba, Japan.
  • Saito K; Department of Aging Pharmacology, Faculty of Medicine, Toho University, Tokyo, Japan.
  • Shirasawa H; Department of Applied Chemistry and Biotechnology, Graduate School of Engineering, Chiba University, Chiba, Japan.
Anticancer Res ; 41(2): 699-706, 2021 Feb.
Article em En | MEDLINE | ID: mdl-33517274

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Benzimidazóis / Apoptose / Pontos de Checagem da Fase G1 do Ciclo Celular / Neoplasias / Antineoplásicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Benzimidazóis / Apoptose / Pontos de Checagem da Fase G1 do Ciclo Celular / Neoplasias / Antineoplásicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article